Tag Merck

Merck Healthcare announced a license agreement with Abbisko Therapeutics for pimicotinib, which is currently being evaluated in a Phase 3 study for the treatment of tenosynovial giant cell tumor.

Merck Healthcare today announced a license agreement with Abbisko Therapeutics Co. Ltd, Shanghai, China, for pimicotinib (ABSK021), which is currently being evaluated in a Phase III study for the treatment of tenosynovial giant cell tumor (TGCT). TGCT is a benign…

Merck Healthcare has launched ChemisTwin™.

Merck Healthcare has launched ChemisTwin™, the first digital reference materials platform that can perform automatic analysis of samples’ purity, identification, and degradation of compounds through calibrated algorithm-based digital references. With digital signatures for more than 1,500 reference materials, this automation…